Skip to content

Methylphenidate physiological and physical performance effects

Methylphenidate: Physiological, neurocognitive, balance, and physical performance effects

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
PACTR
Registry ID
PACTR202011697726048
Enrollment
70
Registered
2020-11-11
Start date
2020-02-03
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mental and Behavioural Disorders

Interventions

Methyphenidate active group
Control group

Sponsors

National Lottery Distribution Trust Fund
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Newly diagnosed ADHD children or adults who have not yet started taking the prescribed methylphenidate, or have been drug-naïve for at least 6 months 1. Between the ages of 14- 30 years 2. Participants will be willing to accept that placebo/inactive formulation will be administered for 2 weeks 3. Participants will be willing to volunteer to undergo non-invasive investigations and assessments

Exclusion criteria

Exclusion criteria: 1. The use of any other medication that may affect physical performance, electrocardiogram tracings or balance 2. Any physical or other affliction that may affect the successful completion of the physical performance tests

Design outcomes

Primary

MeasureTime frame
Physiological - ECG, cardiorespiratory fitness, postural balance, muscle strength, psychometry, academic and sport performance

Secondary

MeasureTime frame
Anthropometry - height, weight, waist circumference, BMI

Countries

South Africa

Contacts

Public ContactDidintle Shuping

Administrative assistant

didi.shuping@wits.ac.za+27117173372

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026